Rose Marie Cazzani, | |
45 E Bel Air Rd, Cranston, RI 02920-4525 | |
(401) 392-0564 | |
(401) 435-4231 |
Full Name | Rose Marie Cazzani |
---|---|
Gender | Female |
Speciality | Physical Therapy Assistant |
Location | 45 E Bel Air Rd, Cranston, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255711883 | NPI | - | NPPES |
1255711883 | Other | NPI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | PTA00404 (Rhode Island) | Secondary |
225200000X | Physical Therapy Assistant | PT00404 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rose Marie Cazzani, 45 E Bel Air Rd, Cranston, RI 02920-4525 Ph: (401) 338-0125 | Rose Marie Cazzani, 45 E Bel Air Rd, Cranston, RI 02920-4525 Ph: (401) 392-0564 |
News Archive
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, and AXA Diagnostics, a privately owned company that markets specialized diagnostic tests, announced today the signing of an exclusive distribution agreement in Italy for Rosetta Genomics' three currently available diagnostic tests.
A University of Vermont-led research team has received approval for $18.5 million in funding to study whether patients with both medical and behavioral problems do better when their primary care physicians work in combination with behavioral health professionals including psychologists and social workers.
Three studies coming out of the American Epilepsy Society's 67th Annual Meeting in Washington DC expose the high prevalence of epilepsy and other neurological disorders in US Veterans who served in Operation Enduring Freedom, Operation Iraqi Freedom and Operation New Dawn. The research conducted from these studies indicate that veterans are at a particularly high risk for traumatic brain injury, post traumatic stress disorder, psychological non-epileptic seizures and epileptic seizure diagnoses.
Leading efforts to create an HIV vaccine have hinged on the use of viruses as carriers for selected elements of the HIV virus. Recently, however, evidence has emerged that some of these so-called viral vector systems may undermine the immune system and should not be used for vaccine development.
› Verified 2 days ago